EUR 90.7
(-4.32%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.49 Billion EUR | 10.03% |
2022 | 2.27 Billion EUR | 0.82% |
2021 | 2.25 Billion EUR | 3.38% |
2020 | 2.17 Billion EUR | -14.68% |
2019 | 2.55 Billion EUR | 66.49% |
2018 | 1.53 Billion EUR | -0.14% |
2017 | 1.53 Billion EUR | 44.74% |
2016 | 1.06 Billion EUR | 48.98% |
2015 | 712.4 Million EUR | 10.38% |
2014 | 645.4 Million EUR | 9.09% |
2013 | 591.6 Million EUR | -6.81% |
2012 | 634.83 Million EUR | 2.73% |
2011 | 617.96 Million EUR | 3.17% |
2010 | 598.96 Million EUR | 1.09% |
2009 | 592.52 Million EUR | -15.52% |
2008 | 701.35 Million EUR | 34.41% |
2007 | 521.81 Million EUR | 7.29% |
2006 | 486.36 Million EUR | 51.32% |
2005 | 321.4 Million EUR | -23.83% |
2004 | 421.98 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 2.5 Billion EUR | 0.0% |
2023 Q4 | 2.49 Billion EUR | 0.0% |
2023 FY | 2.49 Billion EUR | 10.03% |
2023 Q2 | 2.68 Billion EUR | 0.0% |
2022 Q2 | 2.44 Billion EUR | 0.0% |
2022 Q4 | 2.27 Billion EUR | 0.0% |
2022 FY | 2.27 Billion EUR | 0.82% |
2021 FY | 2.25 Billion EUR | 3.38% |
2021 Q4 | 2.25 Billion EUR | 0.0% |
2021 Q2 | 2.13 Billion EUR | 0.0% |
2020 FY | 2.17 Billion EUR | -14.68% |
2020 Q2 | 2.37 Billion EUR | 0.0% |
2020 Q4 | 2.19 Billion EUR | 0.0% |
2019 Q2 | 2.82 Billion EUR | 0.0% |
2019 Q4 | 2.55 Billion EUR | 0.0% |
2019 FY | 2.55 Billion EUR | 66.49% |
2018 Q4 | 1.53 Billion EUR | 0.0% |
2018 Q2 | 1.62 Billion EUR | 0.0% |
2018 FY | 1.53 Billion EUR | -0.14% |
2017 FY | 1.53 Billion EUR | 44.74% |
2017 Q4 | 1.53 Billion EUR | 0.0% |
2017 Q2 | 1.55 Billion EUR | 0.0% |
2016 FY | 1.06 Billion EUR | 48.98% |
2016 Q4 | 1.06 Billion EUR | 0.0% |
2016 Q2 | 994.9 Million EUR | 0.0% |
2015 Q4 | 712.4 Million EUR | 0.0% |
2015 FY | 712.4 Million EUR | 10.38% |
2015 Q2 | 626.2 Million EUR | 0.0% |
2014 FY | 645.4 Million EUR | 9.09% |
2014 Q4 | 645.4 Million EUR | 0.0% |
2014 Q2 | 647 Million EUR | 0.0% |
2013 Q2 | 631.78 Million EUR | 0.0% |
2013 FY | 591.6 Million EUR | -6.81% |
2013 Q4 | 591.59 Million EUR | 0.0% |
2012 FY | 634.83 Million EUR | 2.73% |
2012 Q4 | 634.83 Million EUR | 300.0% |
2012 Q3 | 158.7 Million EUR | -72.65% |
2012 Q2 | 580.3 Million EUR | 265.64% |
2012 Q1 | 158.7 Million EUR | -74.32% |
2011 Q1 | 154.49 Million EUR | -74.21% |
2011 FY | 617.96 Million EUR | 3.17% |
2011 Q4 | 617.96 Million EUR | 300.0% |
2011 Q3 | 154.49 Million EUR | -74.27% |
2011 Q2 | 600.5 Million EUR | 288.69% |
2010 Q3 | 149.74 Million EUR | -76.19% |
2010 FY | 598.96 Million EUR | 1.09% |
2010 Q1 | 149.74 Million EUR | -74.73% |
2010 Q2 | 628.77 Million EUR | 319.91% |
2010 Q4 | 598.96 Million EUR | 300.0% |
2009 Q3 | 148.13 Million EUR | 0.0% |
2009 Q1 | 148.13 Million EUR | -15.52% |
2009 Q2 | 148.13 Million EUR | 0.0% |
2009 Q4 | 592.52 Million EUR | 300.0% |
2009 FY | 592.52 Million EUR | -15.52% |
2008 Q1 | 175.33 Million EUR | 34.41% |
2008 Q4 | 175.33 Million EUR | 0.0% |
2008 Q3 | 175.33 Million EUR | 0.0% |
2008 Q2 | 175.33 Million EUR | 0.0% |
2008 FY | 701.35 Million EUR | 34.41% |
2007 Q4 | 130.45 Million EUR | 0.0% |
2007 Q3 | 130.45 Million EUR | 0.0% |
2007 Q2 | 130.45 Million EUR | 0.0% |
2007 FY | 521.81 Million EUR | 7.29% |
2007 Q1 | 130.45 Million EUR | 7.29% |
2006 Q1 | 121.59 Million EUR | 51.32% |
2006 Q4 | 121.59 Million EUR | 0.0% |
2006 FY | 486.36 Million EUR | 51.32% |
2006 Q2 | 121.59 Million EUR | 0.0% |
2006 Q3 | 121.59 Million EUR | 0.0% |
2005 Q4 | 80.35 Million EUR | 0.0% |
2005 Q1 | 80.35 Million EUR | -23.83% |
2005 Q2 | 80.35 Million EUR | 0.0% |
2005 Q3 | 80.35 Million EUR | 0.0% |
2005 FY | 321.4 Million EUR | -23.83% |
2004 Q3 | 105.49 Million EUR | 0.0% |
2004 Q1 | 105.49 Million EUR | 0.0% |
2004 FY | 421.98 Million EUR | 0.0% |
2004 Q4 | 105.49 Million EUR | 0.0% |
2004 Q2 | 105.49 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
AB Science S.A. | 46.5 Million EUR | -5273.269% |
Boiron SA | 198.7 Million EUR | -1157.669% |
Malin Corporation plc | 7.1 Million EUR | -35097.183% |
Vetoquinol SA | 165.12 Million EUR | -1413.426% |